Sweden· SE-20050225000112
Depo-Medrol cum lidocain 40 mg/ml+10 mg/ml Injektionsvätska, suspension
A medicinal product containing lidocaine hydrochloride monohydrate + methylprednisolone acetate, registered in Sweden by Orifarm AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Lidocaine Hydrochloride Monohydrate + Methylprednisolone Acetate
- Manufacturer
- Orifarm AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- June 25, 2026
Packs & prices · 1
- se_varunummer20050225000112
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lidocaine hydrochloride monohydrate + methylprednisolone acetate in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDepo-Medrone with Lidocaine suspension for injection 1ml vialsMawdsley-Brooks & Company Ltd
- SwitzerlandDepo Medrol Lidocain
- NetherlandsDepo Medrol + Lidocaïne, suspensie voor injectiePfizer B.V.
- PolandDepo-Medrol z LidokainąPfizer Europe MA EEIG
- IrelandDepo-Medrone 40mg/ml with Lidocaine 10mg/ml Suspension for Injection, 2ml vialPfizer Healthcare Ireland Unlimited Company
- FinlandDepo-Medrol Cum LidocainPfizer Oy
- CanadaDEPO-MEDROL WITH LIDOCAINEPFIZER CANADA ULC
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Belgium · Depo-Medrol + Lidocain, Depo-Medrol + Lidocaïne
- Finland · Depo-Medrol Cum Lidocain
- United Kingdom (Northern Ireland) · Depo-Medrone With Lidocaine
- Ireland · Depo-Medrone With Lidocaine
- Italy · Lidodepomedrol
- Luxembourg · Depo-Medrol + Lidocain, Depo-Medrol + Lidocaïne
- Netherlands · Depo-Medrol + Lidocaïne
- Poland · Depo-Medrol Z Lidokainą
- Portugal · Depo-Medrol Com Lidocaína
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cd012ca7-0675-4503-a3af-589a0b8f48ca GET /v1/drugs/cd012ca7-0675-4503-a3af-589a0b8f48ca?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL"
],
"se_npl_id": "20050225000112",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20050225000112",
"product_doc_link": "https://docetp.mpa.se/LMF/Depo-Medrol%20cum%20lidocain%2040%20mg%20per%20ml_10%20mg%20per%20ml%20suspension%20for%20injection%20PT%20PL_09001bee807a0f21.pdf"
}See everything about lidocaine hydrochloride monohydrate + methylprednisolone acetate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.